Last reviewed · How we verify

NCT05872178

Omegia Softgel Clinical Research Program

Completed NA Last updated 24 May 2023
What this trial tests

NA trial testing Omegia® Softgel -B in Skin Manifestations in 40 participants. Completed in 31 December 2022.

Timeline
15 April 2021
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorChia Nan University of Pharmacy & Science
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment40
Start date15 April 2021
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chia Nan University of Pharmacy & Science

Who can join

Adults 45 to 75, female only, with Skin Manifestations or Antioxidative Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the improvement of regulation of skin and blood index composition after consumption of Omegia® Softgel

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Skin Manifestations

Currently open trials in the same condition.

Other Chia Nan University of Pharmacy & Science trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05872178.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing